Inactive Instrument

ZINZINO Share Price Swiss Exchange

Equities

SE0002480442

Other Specialty Retailers

End-of-day quote Swiss Exchange
- SEK - Intraday chart for ZINZINO

Financials

Sales 2024 * 1.92B 177M 14.06B Sales 2025 * 2.06B 190M 15.11B Capitalization 2.85B 262M 20.89B
Net income 2024 * 179M 16.49M 1.31B Net income 2025 * 195M 17.97M 1.43B EV / Sales 2024 * 1.6 x
Net Debt 2024 * 221M 20.36M 1.62B Net Debt 2025 * 158M 14.56M 1.16B EV / Sales 2025 * 1.46 x
P/E ratio 2024 *
16.5 x
P/E ratio 2025 *
15.2 x
Employees -
Yield 2024 *
2.4%
Yield 2025 *
2.1%
Free-Float 53.08%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 54 31/12/11
Director of Finance/CFO 47 31/12/08
Chief Tech/Sci/R&D Officer 48 31/12/17
Members of the board TitleAgeSince
Director/Board Member 60 31/12/06
Director/Board Member 56 -
Director/Board Member 52 -
More insiders
Zinzino AB is a Sweden-based global Company engaged in selling dietary supplements, skin care and lifestyle products. The Company specializes in biomarker-based, personalized nutrition and health tech. The Company’s test-based, scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino AB owns the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The Company’s headquarter is in Gothenburg, Sweden with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong, Malaysia and India.
Calendar
More about the company